Table 2 Clinical characteristics of HIV-infected women (n=2,501)
From: Cervical cancer risk factors among HIV-infected Nigerian women
| Â | n (%) | Missing (%) |
|---|---|---|
BMI (kg/m2) | Â | 1840 (73.6) |
   <18.5 | 46 (7) |  |
   18.5–24.9 | 401 (61) |  |
   25–29.9 | 49 (7) |  |
   ≥30 | 165 (25) |  |
Vaginal wall abnormality | Â | 0 (0) |
   None | 2241 (90) |  |
   Other1 | 260 (10) |  |
VIA | Â | 0 (0) |
   Negative | 2344 (94) |  |
   Positive | 155 (6) |  |
   Invasive cancer | 2 (0) |  |
Last CD4 count (per mm3) | Â | 365 (14.6) |
   <300 | 490 (23) |  |
   300–<450 | 560 (26) |  |
   450–<650 | 592 (28) |  |
   ≥650 | 494 (23) |  |
WHO stage | Â | 1118 (44.7) |
   Stage 1 | 1185 (86) |  |
   Stage 2 | 104 (7) |  |
   Stage 3 | 84 (6) |  |
   Stage 4 | 10 (1) |  |
ART regimen currently on2 | Â | 1008 (40) |
   TDF-containing ART3 | 778 (52) |  |
   ZDV-containing ART4 | 600 (40) |  |
   d4T-containing ART5 | 115 (8) |  |